MGH Harvard - Site #369 — Boston, Massachusetts

MGH Harvard - Site #369 is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

MGH Harvard - Site #369 has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Immunoglobulin A Nephropathy.

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc..

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MGH Harvard - Site #369?

MGH Harvard - Site #369 has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MGH Harvard - Site #369 conducted?

MGH Harvard - Site #369 has 2 clinical trials on record, with 2 currently active. Their work covers Immunoglobulin A Nephropathy.

Is MGH Harvard - Site #369 accredited by Crixeo Health?

MGH Harvard - Site #369 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MGH Harvard - Site #369?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.